The University of Chicago Header Logo

Piyush Agarwal

TitleProfessor
InstitutionUniversity of Chicago
DepartmentSurgery-Urology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dahmen AS, Nusbaum DJ, Lazarovich A, Fialkoff J, Modi PK, Agarwal PK. Trends in the use of immediate postoperative intravesical chemotherapy following transurethral resection of bladder tumors. Urol Oncol. 2024 Oct 22. PMID: 39443253.
      Citations:    Fields:    
    2. Shukla D, Hyman MJ, Agarwal PK, Faris S, Skolarus TA, Modi PK. Urologic oncology case volume among early career urologists: An analysis of certification data from the American board of urology between 2003 and 2019. Urol Oncol. 2024 Oct 10. PMID: 39393994.
      Citations:    Fields:    
    3. Dahmen AS, Lazarovich A, Nusbaum DJ, Katebian B, Modi P, Agarwal PK. The impact of metabolic syndrome on short term radical cystectomy complications. Urol Oncol. 2024 Jul 10. PMID: 38991869.
      Citations:    Fields:    
    4. Apolo AB, Girardi DM, Niglio SA, Nadal R, Kydd AR, Simon N, Ley L, Cordes LM, Chandran E, Steinberg SM, Lee S, Lee MJ, Rastogi S, Sato N, Cao L, Banday AR, Boudjadi S, Merino MJ, Toubaji A, Akbulut D, Redd B, Bagheri H, Costello R, Gurram S, Agarwal PK, Chalfin HJ, Valera V, Streicher H, Wright JJ, Sharon E, Figg WD, Parnes HL, Gulley JL, Saraiya B, Pal SK, Quinn D, Stein MN, Lara PN, Bottaro DP, Mortazavi A. Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. J Clin Oncol. 2024 Sep 01; 42(25):3033-3046. PMID: 38954785; PMCID: PMC11361361.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    5. Agarwal PK, Sternberg CN. Clinical Trials Corner Issue 10(2). Bladder Cancer. 2024; 10(2):157-160. PMID: 39131876; PMCID: PMC11308633.
      Citations:    Translation:CTClinical Trials
    6. Watt KD, Rolak S, Foley DP, Plichta JK, Pruthi S, Farr D, Zwald FO, Carvajal RD, Dudek AZ, Sanger CB, Rocco R, Chang GJ, Dizon DS, Langstraat CL, Teoh D, Agarwal PK, Al-Qaoud T, Eggener S, Kennedy CC, D'Cunha J, Mohindra NA, Stewart S, Habermann TH, Schuster S, Lunning M, Shah NN, Gertz MA, Mehta J, Suvannasankha A, Verna E, Farr M, Blosser CD, Hammel L, Al-Adra DP. Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion. Transplantation. 2024 May 21. PMID: 38771067.
      Citations:    Fields:    
    7. Dahmen A, Agarwal PK, Modi PK. Editorial Comment. J Urol. 2024 Jun; 211(6):750-751. PMID: 38721935.
      Citations:    Fields:    
    8. Hyman MJ, Skolarus TA, Cabral J, Shewmon K, Bedziner M, Agarwal PK, Modi PK. Utilization and Timing of Cystoscopy for Hematuria Evaluation by Advanced Practice Providers and Urologists. Urology. 2024 Jun; 188:80-86. PMID: 38663584.
      Citations:    Fields:    Translation:Humans
    9. Agarwal PK, Sternberg CN. Clinical Trials Corner Issue 10(1). Bladder Cancer. 2024; 10(1):83-87. PMID: 38993530; PMCID: PMC11181815.
      Citations:    Translation:CTClinical Trials
    10. Jhaveri JK, Dahmen A, Lazarovich A, Nusbaum D, Trinh QD, Gupta N, Agarwal PK. Necrotizing granulomatous epididymo-orchitis post intravesical BCG administration after brachytherapy for prostate cancer. Urol Case Rep. 2024 May; 54:102694. PMID: 38516176; PMCID: PMC10951466.
      Citations:    
    11. Dall CP, Mason JB, Goldman CC, Fabrizio G, Alagha EC, Chou J, Kowalczyk KJ, Agarwal PK, Stamatakis L, Krasnow RE. Functional and oncologic outcomes of prostate capsule-sparing radical cystectomy: A systematic review and meta-analysis. Urol Oncol. 2024 May; 42(5):121-132. PMID: 38418269.
      Citations:    Fields:    Translation:Humans
    12. Lotan Y, Agarwal P, Black P, Dickstein R, Kamat AM, Lee B, Narayan VM, Porten S, Psutka SP, Smith AK, Svatek RS, Williams SB, Woldu S. Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials. Urol Oncol. 2024 Aug; 42(8):223-228. PMID: 38307803.
      Citations:    Fields:    Translation:Humans
    13. Lynch C, Sweis RF, Modi P, Agarwal PK, Szmulewitz RZ, Stadler WM, O'Donnell PH, Liauw SL, Pitroda SP. Bladder-Preserving Trimodality Therapy With Capecitabine. Clin Genitourin Cancer. 2024 04; 22(2):476-482.e1. PMID: 38228414.
      Citations:    Fields:    Translation:Humans
    14. Agarwal PK, Sternberg CN. Clinical Trials Corner Issue 9(4). Bladder Cancer. 2023; 9(4):377-381. PMID: 38994245; PMCID: PMC11165933.
      Citations:    
    15. Agarwal PK, Sternberg CN. Clinical Trials Corner Issue 9(2). Bladder Cancer. 2023; 9(2):187-190. PMID: 38993295; PMCID: PMC11181763.
      Citations:    Translation:CTClinical Trials
    16. Agarwal PK, Sternberg CN. Clinical Trials Corner Issue 9(1). Bladder Cancer. 2023; 9(1):101-103. PMID: 38994478; PMCID: PMC11181823.
      Citations:    Translation:CTClinical Trials
    17. Agarwal PK, Sternberg CN. Clinical Trials Corner Issue 8(4). Bladder Cancer. 2022; 8(4):423-425. PMID: 38994182; PMCID: PMC11181697.
      Citations:    Translation:CTClinical Trials
    18. Agarwal PK, Sternberg CN. Clinical Trials Corner Issue 8(2). Bladder Cancer. 2022; 8(2):233-235. PMID: 38993363; PMCID: PMC11181695.
      Citations:    Translation:CTClinical Trials
    19. Labbate CV, Kuchta K, Park S, Agarwal PK, Smith ND. AUTHOR REPLY. Urology. 2022 06; 164:177. PMID: 35710169.
      Citations:    Fields:    
    20. Paner GP, Smith SC, Hartmann A, Agarwal PK, Amin MB, Compérat E. Flat intraurothelial lesions of the urinary bladder-do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice. Mod Pathol. 2022 10; 35(10):1296-1305. PMID: 35468997.
      Citations:    Fields:    Translation:Humans
    21. Agarwal PK, Sternberg CN. Clinical Trials Corner Issue 8(1). Bladder Cancer. 2022; 8(1):93-95. PMID: 38994518; PMCID: PMC11181851.
      Citations: 1     Translation:CTClinical Trials
    22. Labbate CV, Kuchta K, Park S, Agarwal PK, Smith ND. Incidence of Preoperative Antibiotic Use and Its Association with Postoperative Infectious Complications after Radical Cystectomy. Urology. 2022 06; 164:169-177. PMID: 35218864.
      Citations:    Fields:    Translation:Humans
    23. Walia AS, Sweis RF, Agarwal PK, Kader AK, Modi PK. Cost-Effectiveness of Immune Checkpoint Inhibitors in Urothelial Carcinoma-A Review. Cancers (Basel). 2021 Dec 24; 14(1). PMID: 35008237; PMCID: PMC8750958.
      Citations: 2     
    24. Agarwal PK, Sternberg CN. Clinical Trials Corner Issue 7(4). Bladder Cancer. 2021; 7(4):481-484. PMID: 38993993; PMCID: PMC11181698.
      Citations:    Translation:CTClinical Trials
    25. Singh A, Faris S, Agarwal P, Reynolds LF, Modi PK. Association between Industry Payments and Published Position on Use of Devices for the Treatment of Lower Urinary Tract Symptoms. Urology. 2022 01; 159:87-92. PMID: 34752849.
      Citations:    Fields:    Translation:Humans
    26. Agarwal PK, Sternberg CN. Clinical Trials Corner Issue 7(3). Bladder Cancer. 2021; 7(3):381-384. PMID: 38993606; PMCID: PMC11181720.
      Citations:    
    27. Agarwal PK, Sfakianos JP, Feldman A, Tagawa ST, Black PC. A 25-year perspective on advances in an understanding of the biology, evaluation, treatment and future directions/challenges of urothelial cancer. Urol Oncol. 2021 09; 39(9):528-547. PMID: 34332848.
      Citations:    Fields:    Translation:Humans
    28. Lee YH, Lee MM, De Silva DM, Roy A, Wright CE, Wong TK, Costello R, Olaku O, Grubb RL, Agarwal PK, Apolo AB, Bottaro DP. Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder. PLoS One. 2021; 16(7):e0241766. PMID: 34292953; PMCID: PMC8297783.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    29. Tatjana A, Tjota MY, O'Donnell PH, Eggener SE, Agarwal PK, Haridas R, Segal J, Wang P. EZR-ROS1 fusion renal cell carcinoma mimicking urothelial carcinoma: report of a previously undescribed gene fusion in renal cell carcinoma. Virchows Arch. 2022 Feb; 480(2):487-492. PMID: 34128116.
      Citations: 2     Fields:    Translation:Humans
    30. Agarwal PK, Sternberg CN. Clinical Trials Corner Issue 7(2). Bladder Cancer. 2021; 7(2):257-260. PMID: 38994540; PMCID: PMC11181678.
      Citations:    
    31. Saoud R, Sanford TH, Hewitt SM, Apolo AB, Agarwal PK. Rapidly Progressing Urothelial Carcinoma Due to a Rare TP53 (p.Arg110Pro) Mutation: A Case Report and Review of the Literature. Res Rep Urol. 2021; 13:181-184. PMID: 33907694; PMCID: PMC8068478.
      Citations:    
    32. Agarwal PK, Sternberg CN. Clinical Trials Corner Issue 7(1). Bladder Cancer. 2021; 7(1):103-106. PMID: 38993219; PMCID: PMC11181792.
      Citations:    
    33. Eggener SE, Agarwal PK. Re: Pretransplant Solid Organ Malignancy and Organ Transplant Candidacy: A Consensus Expert Opinion Statement. Eur Urol. 2021 04; 79(4):552-553. PMID: 33303242.
      Citations:    Fields:    Translation:Humans
    34. Gastman B, Agarwal PK, Berger A, Boland G, Broderick S, Butterfield LH, Byrd D, Fecci PE, Ferris RL, Fong Y, Goff SL, Grabowski MM, Ito F, Lim M, Lotze MT, Mahdi H, Malafa M, Morris CD, Murthy P, Neves RI, Odunsi A, Pai SI, Prabhakaran S, Rosenberg SA, Saoud R, Sethuraman J, Skitzki J, Slingluff CL, Sondak VK, Sunwoo JB, Turcotte S, Yeung CC, Kaufman HL. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee. J Immunother Cancer. 2020 11; 8(2). PMID: 33199512; PMCID: PMC7670953.
      Citations: 16     Fields:    Translation:Humans
    35. Al-Adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, Verna E, Locke J, D'Cunha J, Farr M, Sawinski D, Agarwal PK, Plichta J, Pruthi S, Farr D, Carvajal R, Walker J, Zwald F, Habermann T, Gertz M, Bierman P, Dizon DS, Langstraat C, Al-Qaoud T, Eggener S, Richgels JP, Chang GJ, Geltzeiler C, Sapisochin G, Ricciardi R, Krupnick AS, Kennedy C, Mohindra N, Foley DP, Watt KD. Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement. Am J Transplant. 2021 02; 21(2):460-474. PMID: 32969590; PMCID: PMC8576374.
      Citations: 31     Fields:    Translation:Humans
    36. Al-Adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, Verna E, Locke J, D'Cunha J, Farr M, Sawinski D, Agarwal PK, Plichta J, Pruthi S, Farr D, Carvajal R, Walker J, Zwald F, Habermann T, Gertz M, Bierman P, Dizon DS, Langstraat C, Al-Qaoud T, Eggener S, Richgels JP, Chang GJ, Geltzeiler C, Sapisochin G, Ricciardi R, Krupnick AS, Kennedy C, Mohindra N, Foley DP, Watt KD. Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement. Am J Transplant. 2021 02; 21(2):475-483. PMID: 32976703; PMCID: PMC8555431.
      Citations: 23     Fields:    Translation:Humans
    37. Apolo AB, Nadal R, Girardi DM, Niglio SA, Ley L, Cordes LM, Steinberg SM, Sierra Ortiz O, Cadena J, Diaz C, Mallek M, Davarpanah NN, Costello R, Trepel JB, Lee MJ, Merino MJ, Bagheri MH, Monk P, Figg WD, Gulley JL, Agarwal PK, Valera V, Chalfin HJ, Jones J, Streicher H, Wright JJ, Ning YM, Parnes HL, Dahut WL, Bottaro DP, Lara PN, Saraiya B, Pal SK, Stein MN, Mortazavi A. Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors. J Clin Oncol. 2020 11 01; 38(31):3672-3684. PMID: 32915679; PMCID: PMC7605393.
      Citations: 54     Fields:    Translation:HumansCellsCTClinical Trials
    38. Apolo AB, Nadal R, Tomita Y, Davarpanah NN, Cordes LM, Steinberg SM, Cao L, Parnes HL, Costello R, Merino MJ, Folio LR, Lindenberg L, Raffeld M, Lin J, Lee MJ, Lee S, Alarcon SV, Yuno A, Dawson NA, Allette K, Roy A, De Silva D, Lee MM, Sissung TM, Figg WD, Agarwal PK, Wright JJ, Ning YM, Gulley JL, Dahut WL, Bottaro DP, Trepel JB. Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial. Lancet Oncol. 2020 08; 21(8):1099-1109. PMID: 32645282; PMCID: PMC8236112.
      Citations: 46     Fields:    Translation:HumansCTClinical Trials
    39. Harmon SA, Sanford TH, Brown GT, Yang C, Mehralivand S, Jacob JM, Valera VA, Shih JH, Agarwal PK, Choyke PL, Turkbey B. Multiresolution Application of Artificial Intelligence in Digital Pathology for Prediction of Positive Lymph Nodes From Primary Tumors in Bladder Cancer. JCO Clin Cancer Inform. 2020 04; 4:367-382. PMID: 32330067; PMCID: PMC7259877.
      Citations: 16     Fields:    Translation:Humans
    40. Turkbey B, Czarniecki M, Shih JH, Harmon SA, Agarwal PK, Apolo AB, Citrin DE, Gulley JL, Harisinghani M, Madan RA, Metwalli AR, Paquette E, Pinto PA, Rais-Bahrami S, Rowe LS, Wood BJ, Jacobs PM, Lindenberg L, Dahut W, Choyke PL. Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study. AJR Am J Roentgenol. 2020 01; 214(1):105-113. PMID: 31613660; PMCID: PMC8258657.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    41. Leko V, McDuffie LA, Zheng Z, Gartner JJ, Prickett TD, Apolo AB, Agarwal PK, Rosenberg SA, Lu YC. Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer. J Immunol. 2019 06 15; 202(12):3458-3467. PMID: 31036766; PMCID: PMC6548619.
      Citations: 24     Fields:    Translation:HumansCells
    42. Siddiqui MR, Railkar R, Sanford T, Crooks DR, Eckhaus MA, Haines D, Choyke PL, Kobayashi H, Agarwal PK. Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT). Sci Rep. 2019 02 14; 9(1):2084. PMID: 30765854; PMCID: PMC6375935.
      Citations: 36     Fields:    Translation:HumansAnimalsCells
    43. Agarwal PK, Sternberg CN. Clinical Trials Corner. Bladder Cancer. 2018 Oct 29; 4(4):447-449. PMID: 30417057; PMCID: PMC6218109.
      Citations:    
    44. Rayn KN, Hale GR, Bloom JB, Gold SA, Carvalho FLF, Mehralivand S, Czarniecki M, Wood BJ, Merino MJ, Choyke P, Türkbey B, Pinto PA, Agarwal PK. Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience. Diagn Interv Radiol. 2018 Sep; 24(5):316-320. PMID: 30211685; PMCID: PMC6135055.
      Citations: 5     Fields:    Translation:Humans
    45. Monteiro LL, Witjes JA, Agarwal PK, Anderson CB, Bivalacqua TJ, Bochner BH, Boormans JL, Chang SS, McKiernan JM, Dinney C, Godoy G, Kulkarni GS, Mariappan P, O'Donnell MA, Rentsch CA, Shah JB, Svatek RS, van der Heijden AG, van Valenberg FJP, Kassouf W, Domínguez-Escrig JL, Solsona E. ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer. World J Urol. 2019 Jan; 37(1):51-60. PMID: 30109483.
      Citations: 19     Fields:    Translation:Humans
    46. Agarwal PK, Sternberg CN. Clinical Trials Corner. Bladder Cancer. 2018 Jul 30; 4(3):347-350. PMID: 30112447; PMCID: PMC6087452.
      Citations:    
    47. Rayn KN, Ritchie C, Folio LR, Stamatakis L, Verghese MM, Agarwal PK. Bilateral Ureteroenteric Strictures: A Case of the "Reverse 7". Urology. 2018 Aug; 118:e3-e4. PMID: 29729367; PMCID: PMC7983164.
      Citations: 2     Fields:    Translation:Humans
    48. Agarwal PK, Sternberg CN. Clinical Trials Corner. Bladder Cancer. 2018 Apr 26; 4(2):243-244. PMID: 29951574; PMCID: PMC5929298.
      Citations:    
    49. Sanford T, Meng MV, Railkar R, Agarwal PK, Porten SP. Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma. Clin Epigenetics. 2018; 10:19. PMID: 29456764; PMCID: PMC5809922.
      Citations: 16     Fields:    Translation:HumansCells
    50. Agarwal PK, Sternberg CN. Clinical Trials Corner. Bladder Cancer. 2018 Jan 20; 4(1):133-136. PMID: 29430515; PMCID: PMC5798534.
      Citations:    
    51. Maruf M, Sidana A, Purnell S, Jain AL, Brancato SJ, Agarwal PK. Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database. Int Urol Nephrol. 2018 Feb; 50(2):257-262. PMID: 29275528; PMCID: PMC7983165.
      Citations: 2     Fields:    Translation:Humans
    52. Agarwal PK. Editorial Comment. J Urol. 2018 02; 199(2):414-415. PMID: 29131984.
      Citations:    Fields:    Translation:Humans
    53. Agarwal PK, Sternberg CN. Clinical Trials Corner. Bladder Cancer. 2017 Oct 27; 3(4):315-317. PMID: 29152557; PMCID: PMC5676764.
      Citations:    
    54. Li QQ, Hsu I, Sanford T, Railkar R, Balaji N, Sourbier C, Vocke C, Balaji KC, Agarwal PK. Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M. Cell Mol Life Sci. 2018 03; 75(5):939-963. PMID: 29071385; PMCID: PMC7984729.
      Citations: 21     Fields:    Translation:HumansAnimalsCells
    55. Maruf M, Agarwal PK, Sidana A. The Sunshine Act and oncology: Lessons learned from urology. Semin Oncol. 2017 08; 44(4):265-266. PMID: 29526254; PMCID: PMC8171588.
      Citations:    Fields:    Translation:Humans
    56. Siddiqui MR, Grant C, Sanford T, Agarwal PK. Current clinical trials in non-muscle invasive bladder cancer. Urol Oncol. 2017 08; 35(8):516-527. PMID: 28778250; PMCID: PMC5556973.
      Citations: 14     Fields:    Translation:Humans
    57. Agarwal PK, Sternberg CN. Clinical Trials Corner. Bladder Cancer. 2017 Jul 27; 3(3):229-230. PMID: 28824952; PMCID: PMC5545916.
      Citations:    
    58. Railkar R, Krane LS, Li QQ, Sanford T, Siddiqui MR, Haines D, Vourganti S, Brancato SJ, Choyke PL, Kobayashi H, Agarwal PK. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer. Mol Cancer Ther. 2017 10; 16(10):2201-2214. PMID: 28619755; PMCID: PMC5628127.
      Citations: 42     Fields:    Translation:HumansAnimalsCells
    59. Strich J, Brancato S, Dolan R, Maruf M, Siddiqui MR, Sanford T, Zerbe C, Agarwal PK. Case Presentation: Lung Consolidation as Sequelae of BCG Sepsis After Combined Intravesical and Intraurethral BCG. Urol Case Rep. 2017 Jul; 13:152-153. PMID: 28567334; PMCID: PMC5440684.
      Citations: 1     
    60. Bagheri MH, Ahlman MA, Lindenberg L, Turkbey B, Lin J, Cahid Civelek A, Malayeri AA, Agarwal PK, Choyke PL, Folio LR, Apolo AB. Advances in medical imaging for the diagnosis and management of common genitourinary cancers. Urol Oncol. 2017 07; 35(7):473-491. PMID: 28506596; PMCID: PMC5931389.
      Citations: 20     Fields:    Translation:Humans
    61. Mikhail AS, Negussie AH, Pritchard WF, Haemmerich D, Woods D, Bakhutashvili I, Esparza-Trujillo J, Brancato SJ, Karanian J, Agarwal PK, Wood BJ. Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer. Int J Hyperthermia. 2017 11; 33(7):733-740. PMID: 28540814; PMCID: PMC7676871.
      Citations: 11     Fields:    Translation:Animals
    62. Agarwal PK, Sternberg CN. Clinical Trials Corner. Bladder Cancer. 2017 Apr 27; 3(2):141-142. PMID: 28516160; PMCID: PMC5409041.
      Citations:    
    63. Maruf M, Sidana A, Fleischman W, Brancato SJ, Purnell S, Agrawal S, Agarwal PK. Financial Relationships between Urologists and Industry: An Analysis of Open Payments Data. Urol Pract. 2018 May; 5(3):180-186. PMID: 37300223.
      Citations: 5     Fields:    
    64. Purnell S, Sidana A, Maruf M, Grant C, Agarwal PK. Genitourinary paraganglioma: Demographic, pathologic, and clinical characteristics in the surveillance, epidemiology, and end results database (2000-2012). Urol Oncol. 2017 07; 35(7):457.e9-457.e14. PMID: 28325651; PMCID: PMC5476479.
      Citations: 15     Fields:    Translation:Humans
    65. Li QQ, Hao JJ, Zhang Z, Krane LS, Hammerich KH, Sanford T, Trepel JB, Neckers L, Agarwal PK. Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics. Sci Rep. 2017 03 15; 7(1):201. PMID: 28298630; PMCID: PMC5427839.
      Citations: 31     Fields:    Translation:HumansCells
    66. Hussein AA, Hinata N, Dibaj S, May PR, Kozlowski JD, Abol-Enein H, Abaza R, Eun D, Khan MS, Mohler JL, Agarwal P, Pohar K, Sarle R, Boris R, Mane SS, Hutson A, Guru KA. Development, validation and clinical application of Pelvic Lymphadenectomy Assessment and Completion Evaluation: intraoperative assessment of lymph node dissection after robot-assisted radical cystectomy for bladder cancer. BJU Int. 2017 06; 119(6):879-884. PMID: 27987527; PMCID: PMC8177005.
      Citations: 6     Fields:    Translation:Humans
    67. Siddiqui MR, Sanford T, Nair A, Zerbe CS, Hughes MS, Folio L, Agarwal PK, Brancato SJ. Chronic Colovesical Fistula Leading to Chronic Urinary Tract Infection Resulting in End-Stage Renal Disease in a Chronic Granulomatous Disease Patient. Urol Case Rep. 2017 Feb; 11:37-38. PMID: 28083485; PMCID: PMC5226852.
      Citations: 3     
    68. Agarwal PK, Sternberg CN. Clinical Trials Corner. Bladder Cancer. 2016 Oct 27; 2(4):469-471. PMID: 28035329; PMCID: PMC5181657.
      Citations:    
    69. Kamat AM, Agarwal P, Bivalacqua T, Chisolm S, Daneshmand S, Doroshow JH, Efstathiou JA, Galsky M, Iyer G, Kassouf W, Shah J, Taylor J, Williams SB, Quale DZ, Rosenberg JE. Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think Tank. Bladder Cancer. 2016 Apr 27; 2(2):203-213. PMID: 27376139; PMCID: PMC4927866.
      Citations: 1     
    70. Lara K, Martucci V, Huynh T, Agarwal P, Pacak K, Merino MJ, Giubellino A. Urinary Bladder Paragangliomas: How Immunohistochemistry Can Assist to Identify Patients With SDHB Germline and Somatic Mutations. Am J Surg Pathol. 2015 Nov; 39(11):1488-92. PMID: 26457353; PMCID: PMC4606469.
      Citations: 6     Fields:    Translation:Humans
    71. DiBianco JM, George AK, Su D, Agarwal PK. Managing noninvasive recurrences after definitive treatment for muscle-invasive bladder cancer or high-grade upper tract urothelial carcinoma. Curr Opin Urol. 2015 Sep; 25(5):468-75. PMID: 26125507.
      Citations: 2     Fields:    Translation:Humans
    72. Premo C, Apolo AB, Agarwal PK, Citrin DE. Trimodality therapy in bladder cancer: who, what, and when? Urol Clin North Am. 2015 May; 42(2):169-80, vii. PMID: 25882559; PMCID: PMC4465095.
      Citations: 20     Fields:    Translation:Humans
    73. Martucci VL, Lorenzo ZG, Weintraub M, del Rivero J, Ling A, Merino M, Siddiqui M, Shuch B, Vourganti S, Linehan WM, Agarwal PK, Pacak K. Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes. Urol Oncol. 2015 Apr; 33(4):167.e13-20. PMID: 25683602; PMCID: PMC4417377.
      Citations: 12     Fields:    Translation:Humans
    74. Lee YH, Apolo AB, Agarwal PK, Bottaro DP. Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder. Cancers (Basel). 2014 Nov 25; 6(4):2313-29. PMID: 25534569; PMCID: PMC4276968.
      Citations: 8     
    75. McNeil BK, Sorbellini M, Grubb RL, Apolo A, Cecchi F, Athauda G, Cohen B, Giubellino A, Simpson H, Agarwal PK, Coleman J, Getzenberg RH, Netto GJ, Shih J, Linehan WM, Pinto PA, Bottaro DP. Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder. J Transl Med. 2014 Oct 21; 12:199. PMID: 25335552; PMCID: PMC4283116.
      Citations: 9     Fields:    Translation:Humans
    76. Nakrani RN, Ghosh A, Richard Lee CC, Agarwal PK, Apolo AB, Cowen EW. New facial papules in a 66-year-old woman with bladder cancer. J Am Acad Dermatol. 2014 Dec; 71(6):1250-5. PMID: 25108634; PMCID: PMC4253599.
      Citations: 2     Fields:    Translation:HumansCells
    77. Park JC, Citrin DE, Agarwal PK, Apolo AB. Multimodal management of muscle-invasive bladder cancer. Curr Probl Cancer. 2014 May-Jun; 38(3):80-108. PMID: 25087173; PMCID: PMC4190161.
      Citations: 45     Fields:    Translation:Humans
    78. Apolo AB, Kim JW, Bochner BH, Steinberg SM, Bajorin DF, Kelly WK, Agarwal PK, Koppie TM, Kaag MG, Quinn DI, Vogelzang NJ, Sridhar SS. Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States. Urol Oncol. 2014 Jul; 32(5):637-44. PMID: 24840869; PMCID: PMC6771274.
      Citations: 23     Fields:    Translation:Humans
    79. Ghosh M, Brancato SJ, Agarwal PK, Apolo AB. Targeted therapies in urothelial carcinoma. Curr Opin Oncol. 2014 May; 26(3):305-20. PMID: 24685646; PMCID: PMC6777561.
      Citations: 23     Fields:    Translation:Humans
    80. Hoang AN, Agarwal PK, Walton-Diaz A, Wood CG, Metwalli AR, Kassouf W, Brown GA, Black PC, Urbauer DL, Grossman HB, Dinney CP, Kamat AM. Clinical significance of ureteric 'skip lesions' at the time of radical cystectomy: the M.D. Anderson experience and literature review. BJU Int. 2014 May; 113(5b):E28-33. PMID: 24053608.
      Citations: 7     Fields:    Translation:Humans
    81. Ahmed K, Khan SA, Hayn MH, Agarwal PK, Badani KK, Balbay MD, Castle EP, Dasgupta P, Ghavamian R, Guru KA, Hemal AK, Hollenbeck BK, Kibel AS, Menon M, Mottrie A, Nepple K, Pattaras JG, Peabody JO, Poulakis V, Pruthi RS, Redorta JP, Rha KH, Richstone L, Saar M, Scherr DS, Siemer S, Stoeckle M, Wallen EM, Weizer AZ, Wiklund P, Wilson T, Woods M, Khan MS. Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol. 2014 Feb; 65(2):340-7. PMID: 24183419.
      Citations: 81     Fields:    Translation:Humans
    82. Trinh QD, Sun M, Kim SP, Sammon J, Kowalczyk KJ, Friedman AA, Sukumar S, Ravi P, Muhletaler F, Agarwal PK, Shariat SF, Hu JC, Menon M, Karakiewicz PI. The impact of hospital volume, residency, and fellowship training on perioperative outcomes after radical prostatectomy. Urol Oncol. 2014 Jan; 32(1):29.e13-20. PMID: 23453659; PMCID: PMC4201949.
      Citations: 10     Fields:    Translation:Humans
    83. Guru KA, Peabody JO, Ahmed K, Kibel A, Weizer A, Hayn M, Johar R, Agarwal P, Balbay M, Hemal A, Muhletaler F, Nepple K, Pattaras J, Redorta J, Rha KH, Richstone L, Saar M, Schanne F, Scherr D, Siemer S, Stoekle M, Wilson T, Woods M, Yuh B, Wiklund P. Reply from authors re: Manfred P. Wirth, Johannes Huber. What really matters is rarely measured: outcome of routine care and patient-reported outcomes. Eur Urol 2013;64:58-9: robot-assisted versus open radical cystectomy: beating a dead horse. Eur Urol. 2013 Jul; 64(1):60-1. PMID: 23522910.
      Citations:    Fields:    Translation:Humans
    84. Marshall SJ, Hayn MH, Stegemann AP, Agarwal PK, Badani KK, Balbay MD, Dasgupta P, Hemal AK, Hollenbeck BK, Kibel AS, Menon M, Mottrie A, Nepple K, Pattaras JG, Peabody JO, Poulakis V, Pruthi RS, Palou Redorta J, Rha KH, Richstone L, Schanne F, Scherr DS, Siemer S, Wallen EM, Weizer AZ, Wiklund P, Wilson T, Woods M, Guru KA, Stöckle M. Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC). BJU Int. 2013 Jun; 111(7):1075-80. PMID: 23442001; PMCID: PMC8366553.
      Citations: 18     Fields:    Translation:Humans
    85. Johar RS, Hayn MH, Stegemann AP, Ahmed K, Agarwal P, Balbay MD, Hemal A, Kibel AS, Muhletaler F, Nepple K, Pattaras JG, Peabody JO, Palou Redorta J, Rha KH, Richstone L, Saar M, Schanne F, Scherr DS, Siemer S, Weizer A, Wiklund P, Wilson T, Woods M, Yuh B, Guru KA, Stökle M. Complications after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol. 2013 Jul; 64(1):52-7. PMID: 23380164.
      Citations: 48     Fields:    Translation:Humans
    86. Kheterpal E, Sammon JD, Diaz M, Bhandari A, Trinh QD, Pokala N, Sharma P, Menon M, Agarwal PK. Effect of metabolic syndrome on pathologic features of prostate cancer. Urol Oncol. 2013 Oct; 31(7):1054-9. PMID: 23020926.
      Citations: 20     Fields:    Translation:Humans
    87. Trinh QD, Sun M, Sammon J, Bianchi M, Sukumar S, Ghani KR, Jeong W, Dabaja A, Shariat SF, Perrotte P, Agarwal PK, Rogers CG, Peabody JO, Menon M, Karakiewicz PI. Disparities in access to care at high-volume institutions for uro-oncologic procedures. Cancer. 2012 Sep 15; 118(18):4421-6. PMID: 22298310.
      Citations: 27     Fields:    Translation:Humans
    88. Agarwal PK. Editorial comment. J Urol. 2011 Apr; 185(4):1261. PMID: 21334657.
      Citations:    Fields:    Translation:Humans
    89. Agarwal PK, Sammon J, Bhandari A, Dabaja A, Diaz M, Dusik-Fenton S, Satyanarayana R, Simone A, Trinh QD, Baize B, Menon M. Safety profile of robot-assisted radical prostatectomy: a standardized report of complications in 3317 patients. Eur Urol. 2011 May; 59(5):684-98. PMID: 21324583.
      Citations: 37     Fields:    Translation:Humans
    90. Black PC, Shetty A, Brown GA, Esparza-Coss E, Metwalli AR, Agarwal PK, McConkey DJ, Hazle JD, Dinney CP. Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosis. BJU Int. 2010 Dec; 106(11):1799-804. PMID: 20500508.
      Citations: 23     Fields:    Translation:AnimalsCells
    91. Krane LS, Kaul SA, Stricker HJ, Peabody JO, Menon M, Agarwal PK. Men presenting for radical prostatectomy on preoperative statin therapy have reduced serum prostate specific antigen. J Urol. 2010 Jan; 183(1):118-24. PMID: 19913252.
      Citations: 18     Fields:    Translation:Humans
    92. Krane LS, Menon M, Kaul SA, Siddiqui SA, Wambi C, Peabody JO, Agarwal PK. Role of PSA velocity in predicting pathologic upgrade for Gleason 6 prostate cancer. Urol Oncol. 2011 Jul-Aug; 29(4):372-7. PMID: 19576796.
      Citations: 5     Fields:    Translation:Humans
    93. Menon M, Shrivastava A, Bhandari M, Satyanarayana R, Siva S, Agarwal PK. Vattikuti Institute prostatectomy: technical modifications in 2009. Eur Urol. 2009 Jul; 56(1):89-96. PMID: 19403236.
      Citations: 36     Fields:    Translation:Humans
    94. Kassouf W, Agarwal PK, Grossman HB, Leibovici D, Munsell MF, Siefker-Radtke A, Pisters LL, Swanson DA, Dinney CP, Kamat AM. Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy. Urology. 2009 Jan; 73(1):147-52. PMID: 18848348; PMCID: PMC2674246.
      Citations: 24     Fields:    Translation:Humans
    95. Kassouf W, Agarwal PK, Herr HW, Munsell MF, Spiess PE, Brown GA, Pisters L, Grossman HB, Dinney CP, Kamat AM. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol. 2008 Jan 01; 26(1):121-6. PMID: 18165646.
      Citations: 46     Fields:    Translation:Humans
    96. Agarwal PK, Black PC, Kamat AM. Considerations on the use of diagnostic markers in management of patients with bladder cancer. World J Urol. 2008 Feb; 26(1):39-44. PMID: 18092171.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    97. Agarwal PK, Black PC, McConkey DJ, Dinney CP. Emerging drugs for targeted therapy of bladder cancer. Expert Opin Emerg Drugs. 2007 Sep; 12(3):435-48. PMID: 17874971.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    98. Black PC, Agarwal PK, Dinney CP. Targeted therapies in bladder cancer--an update. Urol Oncol. 2007 Sep-Oct; 25(5):433-8. PMID: 17826665.
      Citations: 30     Fields:    Translation:Humans
    99. Agarwal PK, Palmer JS. Testicular and paratesticular neoplasms in prepubertal males. J Urol. 2006 Sep; 176(3):875-81. PMID: 16890643.
      Citations: 18     Fields:    Translation:Humans
    100. Agarwal PK, Diaz M, Elder JS. Retractile testis--is it really a normal variant? J Urol. 2006 Apr; 175(4):1496-9. PMID: 16516034.
      Citations: 23     Fields:    Translation:Humans
    101. Agarwal PK, Oefelein MG. Testosterone replacement therapy after primary treatment for prostate cancer. J Urol. 2005 Feb; 173(2):533-6. PMID: 15643240.
      Citations: 58     Fields:    Translation:Humans
    102. Oefelein MG, Agarwal PK, Resnick MI. Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era. J Urol. 2004 Apr; 171(4):1525-8. PMID: 15017212.
      Citations: 16     Fields:    Translation:Humans
    Agarwal's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (312)
    Explore
    _
    Co-Authors (14)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _